BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen R, Wang T, Song J, Pu D, He D, Li J, Yang J, Li K, Zhong C, Zhang J. Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. Int J Nanomedicine 2021;16:4959-84. [PMID: 34326637 DOI: 10.2147/IJN.S315705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Zhang M, Zhao H, Liu Y, Wang T, Lei T, Xiang X, Lu L, Yuan Z, Xu J, Zhang J. Oral supramolecular nanovectors for dual natural medicine codelivery to prevent gastric mucosal lesion. Nanoscale 2022;14:8967-77. [PMID: 35670481 DOI: 10.1039/d2nr01469f] [Reference Citation Analysis]
2 Mukubwa GK, Safari JB, Walker RB, Krause RWM. Design, Manufacturing, Characterization and Evaluation of Lipid Nanocapsules to Enhance the Biopharmaceutical Properties of Efavirenz. Pharmaceutics 2022;14:1318. [DOI: 10.3390/pharmaceutics14071318] [Reference Citation Analysis]
3 Hu X, Jia C, Wu J, Zhang J, Jiang Z, Ma K. Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19. Front Cell Infect Microbiol 2022;12:916012. [DOI: 10.3389/fcimb.2022.916012] [Reference Citation Analysis]
4 Morozova MA, Tumasov VN, Kazimova IV, Maksimova TV, Uspenskaya EV, Syroeshkin AV. Second-Order Scattering Quenching in Fluorescence Spectra of Natural Humates as a Tracer of Formation Stable Supramolecular System for the Delivery of Poorly Soluble Antiviral Drugs on the Example of Mangiferin and Favipiravir. Pharmaceutics 2022;14:767. [DOI: 10.3390/pharmaceutics14040767] [Reference Citation Analysis]
5 Faria MJ, Lopes CM, das Neves J, Lúcio M. Lipid Nanocarriers for Anti-HIV Therapeutics: A Focus on Physicochemical Properties and Biotechnological Advances. Pharmaceutics 2021;13:1294. [PMID: 34452255 DOI: 10.3390/pharmaceutics13081294] [Reference Citation Analysis]